Genedata is the leading global provider of enterprise software solutions that digitalize data-rich and complex biopharmaceutical R&D processes to enable AI approaches for precision medicines.
Incorporating extensive biopharma R&D domain knowledge, Genedata software helps biopharmaceutical organizations optimize workflows, increase research automation, improve experimental data quality, and maximize ROI in R&D expenditure.
Founded in 1997 by Othmar Pfannes, Ph.D., Genedata is privately owned and headquartered in Basel, Switzerland. Sustained organic growth and a strong commitment to its employees are the cornerstones of Genedata’s 25-year history.
With more than 300 employees and offices strategically located throughout Europe, the USA, and Asia, Genedata works closely with leading biopharma and biotech companies around the world. Today, over 200 companies rely on the Genedata Biopharma platform, including all top-25 biopharma companies worldwide, making it the global market leader.
By digitalizing biopharmaceutical R&D processes, the Genedata Biopharma Platform is enabling an R&D revolution driven by precision medicines and artificial intelligence approaches. This will help the industry to deliver innovative biotherapeutics, vaccines and cell & gene therapies to patients more quickly.
- Nominated in 2021
- Winner in 2022